- The majority of people who received Moderna’s COVID-19 vaccine maintained both binding and functional antibodies against coronavirus variants for six months after the second dose, according to a study published in Science. The study looked at the alpha, beta, gamma, delta, epsilon and iota variants.
- Johnson & Johnson’s COVID-19 vaccine was up to 71 percent effective against hospitalization from infection with the delta variant of the coronavirus in a South African study.
- Unvaccinated people are 2.34 times more likely to be reinfected with COVID-19, according to a CDC report that examined data on 246 Kentucky residents who were infected with the virus in 2020.
- Moderna’s COVID-19 vaccine was 93 percent effective for six months after the second dose, according to a clinical trial with 30,000 U.S. participants.
- Fully vaccinated people are 50 percent to 60 percent less likely to become infected with the delta variant of the coronavirus compared to unvaccinated people, according to a study conducted by Imperial College London in England.
